Promising medical therapies for Parkinson's disease / Robert A. Hauser.
Saved in:
| Other Authors: | |
|---|---|
| Format: | Streaming video |
| Language: | English |
| Published: |
London :
Henry Stewart Talks,
2014.
|
| Series: | Henry Stewart talks. Biomedical & life sciences collection. Parkinson's disease.
|
| Subjects: | |
| Online Access: | Henry Stewart Talks: Biomedical & Life Sciences Series |
MARC
| LEADER | 00000ngm a2200000 a 4500 | ||
|---|---|---|---|
| 003 | UkLoHST | ||
| 005 | 20221102220800.0 | ||
| 006 | m c | ||
| 007 | cr|cna|||a|||| | ||
| 007 | vz|czazum | ||
| 008 | 140722s2014 enk041 | |o v|eng d | ||
| 028 | 5 | 0 | |a 3754 |b Henry Stewart Talks |
| 035 | |a (ATU)b25838763 | ||
| 035 | |a (HSTalks)HST3754 | ||
| 040 | |a HSTalks |b eng |d ATU | ||
| 100 | 1 | |a Hauser, Robert A., |e speaker |9 909069 | |
| 245 | 1 | 0 | |a Promising medical therapies for Parkinson's disease / |c Robert A. Hauser. |
| 264 | 1 | |a London : |b Henry Stewart Talks, |c 2014. | |
| 300 | |a 1 streaming video file (41 min.) : |b color, sound. | ||
| 336 | |a two-dimensional moving image |b tdi |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 344 | |a digital | ||
| 347 | |a video file |b MPEG-4 | ||
| 490 | 1 | |a Parkinson's disease, |x 2056-452X | |
| 500 | |a Animated audio-visual presentation with synchronized narration. | ||
| 500 | |a Title from title frames. | ||
| 505 | 0 | |a Contents: Selected Future Therapies for Motor Fluctuations and Dyskinesias -- Ankiparkinsonian agents -- A2a antagonists -- Levodopa preparations -- VR040 (inhaled apomorphine) -- Safinamide (mixed MOA : MAO-B and glu inhibition) -- Anti-dyskinetics -- AFQ056 : mGluR5 antagonist -- ADX48621 (dipraglurant) : mGluR5 negative allosteric modulator -- Fipamezole :a2 adrengergic receptor antagonist -- ADS-5102 : sustained release amantadine. | |
| 538 | |a Mode of access: World Wide Web. | ||
| 650 | 0 | |a Antiparkinsonian agents |x Side effects |9 628416 | |
| 650 | 0 | |a Antiparkinsonian agents. |9 347575 | |
| 650 | 0 | |a Dopa |x Physiological effect |9 770212 | |
| 650 | 0 | |a Parkinson's disease |x Chemotherapy. |9 343487 | |
| 650 | 0 | |a Parkinson's disease |x Treatment |9 701964 | |
| 650 | 2 | |a Adenosine A2 Receptor Antagonists. |9 516692 | |
| 650 | 2 | |a Antiparkinson Agents |x adverse effects. |9 519338 | |
| 650 | 2 | |a Antiparkinson Agents |x therapeutic use. |9 516693 | |
| 650 | 2 | |a Apomorphine |x pharmacokinetics. |9 519339 | |
| 650 | 2 | |a Benzylamines |x pharmacokinetics. |9 519340 | |
| 650 | 2 | |a Dopamine Agonists. |9 519341 | |
| 650 | 2 | |a Dyskinesia, Drug-Induced |x prevention & control. |9 519342 | |
| 650 | 2 | |a Levodopa |x therapeutic use. |9 519343 | |
| 650 | 2 | |a Parkinson Disease |x drug therapy. |9 516538 | |
| 650 | 2 | |a Parkinson Disease |x therapy. |9 519321 | |
| 650 | 2 | |a Receptor, Metabotropic Glutamate 5 |x antagonists & inhibitors. |9 519344 | |
| 830 | 0 | |a Henry Stewart talks. |p Biomedical & life sciences collection. |p Parkinson's disease. | |
| 856 | 4 | 0 | |u http://ezproxy.aut.ac.nz/login?url=https://hstalks.com/bs/2817/ |z Henry Stewart Talks: Biomedical & Life Sciences |
| 856 | 4 | 2 | |u http://ezproxy.aut.ac.nz/login?url=https://hstalks.com/bs/p/805/ |3 Series |
| 907 | |a .b25838763 |b 27-04-21 |c 06-08-18 | ||
| 942 | |c SV | ||
| 998 | |a none |b 27-04-21 |c m |d v |e - |f eng |g enk |h 0 | ||
| 999 | |c 1480669 |d 1480669 | ||